Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 38,698 | 33,580 | 36,145 | 39,679 | 47,670 |
| Cost of Goods | 1,351 | 1,868 | 980 | 939 | 1,426 |
| Gross Profit | 37,347 | 31,712 | 35,165 | 38,740 | 46,244 |
| Operating Expenses | 68,597 | 66,449 | 66,984 | 82,587 | 81,256 |
| Operating Income | -30,899 | -33,869 | -30,839 | -42,908 | -34,586 |
| Interest Expense | 5,758 | 5,885 | 6,114 | 6,313 | 6,684 |
| Other Income | 2,585 | 1,321 | 674 | 280 | 1 |
| Pre-tax Income | -34,072 | -38,433 | -36,279 | -48,941 | -41,269 |
| Income Tax | 54 | 73 | 45 | 121 | 130 |
| Net Income Continuous | -34,126 | -38,506 | -36,324 | -49,062 | -41,399 |
| Net Income | $-34,126 | $-38,506 | $-36,324 | $-49,062 | $-41,399 |
| EPS Basic Total Ops | -4.50 | -6.30 | -6.75 | -9.30 | -7.95 |
| EPS Basic Continuous Ops | -4.51 | -6.24 | -6.79 | -9.23 | -8.00 |
| EPS Diluted Total Ops | -4.50 | -6.30 | -6.75 | -9.30 | -7.95 |
| EPS Diluted Continuous Ops | -4.51 | -6.24 | -6.79 | -9.23 | -8.00 |
| EBITDA(a) | $-31,534 | $-34,010 | $-30,745 | $-42,673 | $-34,166 |